Position in TRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$776,941
-$196,726 QoQ
Shares Held
65,125
-16.3% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 1.472552783109405.ToString("F0")%
Shared 0.ToString("F0")%
None 98.5274472168906.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MAI Capital Management holds $16,329,886 across 273 Biotechnology names. TRVI ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,357 | $4,911,672 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,218 | $990,425 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
46,590 | $894,528 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
3,932 | $785,023 | |
| 5 | TRVI |
Trevi Therapeutics, Inc.
This page
|
65,125 | $776,941 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
72,843 | $558,705 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,477 | $406,641 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,209 | $400,021 |
All Filings in TRVI
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $776,941 | 65,125 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $973,667 | 77,769 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $901,201 | 98,492 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,636,114 | 847,553 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,711,964 | 1,385,050 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,590,370 | 1,356,886 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,433,131 | 1,327,285 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,929,118 | 1,318,496 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,904,782 | 1,131,821 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,714,473 | 1,279,458 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,164,052 | 1,451,400 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,667,818 | 1,534,652 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $2,960,767 | 1,600,415 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $3,320,904 | 1,720,676 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,109,512 | 2,019,164 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $5,732,425 | 2,040,009 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $3,391,236 | 1,541,471 | Shares | Sole | 2022-05-10 | |
| No filing history on record for this holder in this stock. | ||||||